Upstream Scientist
Incyte
Upstream Scientist
Incyte
Biopharmaceutical company pursuing drug discovery.
Description :
The Upstream Scientist in the Bioplant Process Sciences (BPS) department at Yverdon-les-Bains provides upstream expertise to both BPS and the Bioplant. This role supports technology transfers, upstream process development, and the implementation of small-scale models for new recombinant products. The Upstream Scientist also conducts BPS investigations and troubleshooting, leads upstream projects, and contributes expertise in small-scale cell culture bioreactors and related cell monitoring methods. In addition, the role supports raw material procurement for studies and is responsible for process implementation protocols, statistical analysis of results, and study reports within BPS. The Upstream Scientist shares technical knowledge with both BPS and Bioplant teams.
DUTIES AND RESPONSIBILITIES:
REQUIREMENT :
Disclaimer: The above statements are intended to describe the general nature and level of work performed by employees assigned to this job. They are not intended to be an exhaustive list of all duties, responsibilities, and qualifications. Management reserves the right to change or modify such duties as required.
We Respect Your Privacy
Learn more at: http://www.incyte.com/privacy-policy
The Incyte hiring organization processes your personal data to manage your job application in order to enter into an employment relationship with you if you are the successful candidate.
During the process, you may be asked to respond to questions that will screen out your application if you do not meet certain objective criteria required by the job. You can learn more about this process here.
You may have the right to access, delete, restrict, edit, move, or object to the use of your personal data. You may also have a right to report concerns to the authority responsible for data privacy in the country where the position is based or where you live or work.
You can learn more about Incyte’s data protection practices here. By accessing this link you can learn about the types of personal data we collect, how we use it, whether collection and processing is optional, sources of the personal data we process, how it is shared, where it is stored or transferred to, how long we keep it, and contact information for Incyte, Incyte’s data protection officer, and your supervisory authority (if applicable).
Please contact [email protected] if you have any questions or concerns or would like to exercise your rights.
Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.
Explore more opportunities at Incyte